AGER and type 2 diabetes mellitus: Our previous study demonstrated higher AGER expression in patients with long-standing type 2 diabetes compared to that in non-diabetic controls, as well as the association of that RAGE overexpression with cellular apoptotic signal enhancement and osteogenic differentiation impairment.